Amsterdam (ots/PRNewswire) - Advanced MS Care Programme will offer tailored support for MS patients People living with relapsing forms of Multiple Sclerosis (MS) can now access a new Patient Support Programme (PSP) that offers tailored help based on their individual beliefs and support needs. Officially announced ...
Amsterdam (ots/PRNewswire) - Approval of hybrid high-dose fluticasone/salmeterol maintenance treatment for people living with severe asthma and COPD, delivered via the award-winning Spiromax® inhaler to help patient usability Teva Pharmaceutical Industries Ltd., announced today that it has received EU Marketing Authorization for Aerivio Spiromax® ...
Amsterdam (ots/PRNewswire) - Positive conclusion of a European DCP for approval of a tiotropium bromide-based maintenance treatment for those people living with COPD in a new inhaler (Zonda®) Teva Pharmaceutical Industries Ltd., announced today that it has received a positive conclusion of a DCP for BRALTUS® ...
Prague (ots/PRNewswire) - Results from a new study at the 11th Congress of the European Society of Gynecology this week demonstrate that the majority of women in Europe prefer to have less frequent periods. The study recruited 2,883 women aged 18-45 years old from Austria, Belgium, France, Italy, Poland and ...
Amsterdam (ots/PRNewswire) - Teva Pharmaceutical Industries Ltd. today announced that its DuoResp Spiromax(R) inhaler has won silver at the 2015 Medical Design Excellence Awards (MDEA). The awards recognize significant advances in medical product design that improve the quality of healthcare delivery. DuoResp Spiromax(R) (budesonide/formoterol fumarate dihydrate) is a ...